The tax advisors to biotechnology and technology businesses

BUDGET 2019 ANNOUNCED

On November 7, the day following the budget, Confluence Tax will hold an event to debrief #biotech #tech companies on how it will affect your business. Venue: Cambridgeshire; details to follow. All welcome. 

 

How we can help your business

Our services

Business challenges posed by tech and biotech companies are complex and require specialist knowledge to resolve, which is where Confluence Tax steps in. We offer tax advice to help you make the right decisions
to benefit your business and its shareholders.

About us

Confluence Tax is the only UK tax advisory firm to provide advice to businesses and individuals purely within the technology and biotechnology industries. We therefore understand the industry issues and trends and how they relate to the UK tax system and its international aspects.

Contact us

Whatever your query about tax within the biotechnology or technology industries, we're here to help you navigate through it. Talk to us to see how your business – from startup to multinational – can benefit from the right tax advice.

Latest blog posts

Confluence Tax: registered tax agents in Ireland

By CT Team | August 29, 2019

PRESS RELEASE August 29, 2019 We are delighted to announce that Confluence Tax is now registered as a tax agent in the Republic of Ireland. Many UK-based companies that need to retain a foothold within the EU following Brexit – for regulatory reasons, for example – are establishing Irish subsidiaries. This is driving the need for tax advice and support…

PAYE cap on R&D claims – you’ve got to be kidding

By CT Team | July 31, 2019

HM Treasury has consulted on its plans to introduce a cap on R&D tax credit cash claims – of three times a company’s PAYE and NI. And the biotech sector has responded with a resounding “What the…!” The consultation does propose some refinements, such as the ability to include the PAYE and NI of other…

2018 budget: a tax update for biotech and tech businesses

By CT Team | October 2, 2018

  Invitation to the essential 2018 post-budget briefing and general tax update for biotech and tech companies a free event We’ll keep it brief as you’re all busy but we’ll distill the significant bits of Chancellor Philip Hammond’s budget and discuss how they relate to biotech and tech businesses. The Confluence Tax team will be…

Enterprise Management Incentives (EMI) share options guide

By CT Team | August 24, 2018

  Enterprise Management Incentives (EMI) share options guide COMPANIES in the biotech and tech spaces have a constant need to incentivise staff and build motivated teams to prepare them down the line for a sale or investment. Part of that process should include consideration of equity incentives and the tax implications of granting these share…

Rise and fall of film partnerships

By CT Team | June 1, 2018

A tax perspective Tax is our world. We live and breathe it and always find the most tax-efficient – and legal – solutions for our clients, that’s a given. Film partnerships do not generally figure in the tech and biotech niche we inhabit, but they’ve caught our attention in the press recently, so here’s our…

BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?

By CT Team | April 19, 2018

THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…

Should your company elect in to the Patent Box?

By CT Team | February 6, 2018

You’re not out of time but don’t be out of touch… Bad Hall & Oates songs aside, the Patent Box is a complicated beast and 2018 is likely to be a crucial year for determining whether you should elect in. So here is some clarity if yours is a loss-making company. The Patent Box provides…

UK: A GREAT OPTION FOR US R&D

By CT Team | February 6, 2018

WHY THE UK ROCKS FOR RESEARCH During a January visit to San Francisco to coincide with the JP Morgan conference, it was encouraging to hear from one US biotech company CFO how he considered the UK an attractive place to base his company’s research activities – above and beyond any other. Among the reasons why…

HMRC Enterprise Centre: why the delays?

By CT Team | February 6, 2018

IN LIGHT of the November 2017 budget where the Chancellor announced the importance of supporting the R&D sector and growth of small businesses, why are we experiencing delays at the HMRC Enterprise Centre? Confluence Tax’s Anne-Marie Rickels looks at the problems and what can be done. Venture Capital Schemes, such as VCT, EIS and SEIS,…

Employment related securities annual returns – what you need to know

By CT Team | December 1, 2017

EMPLOYMENT related securities (ERS) are a common way of incentivising employees within the technology and biotechnology industries. However, issuing shares or share options results in a reporting obligation to HMRC, the UK tax authorities. This blog aims to answer the most common queries regarding these annual returns. Overview Any company that has given shares or…

Why not sign up to receive our newsletter?

News, comment, tax updates – sign up for our occasional newsletter. We take the security of your data seriously and will never pass it on to anyone else. You can read our privacy policy for details.

Confluence Tax LLP

Registered office: 1010 Cambourne Business Park, Cambourne, Cambridge CB23 6DW, UK

+44 (0)1223 847901

Partnership information

Confluence Tax LLP is a limited liability partnership registered in England, number OC357330

Privacy policy

Disclaimer

The information contained in this website is for general information purposes only. 

Read more